logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Sylvie Chabaud

centre leon berard

46H指数
366论文数
1.0W被引数
收录论文 123
发表时间
logo
Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis不良病理特征对术后放疗联合激素治疗在复发性前列腺癌中潜在获益的影响：一项个体患者数据Meta分析
errEuropean Urology
IF25.2
err2026-07-28
err0
PREAI
errAmar U. Kishan; Yilun Sun; Christopher C. Parker; Paul Sargos; Matthew Sydes; Sylvie Chabaud; Meryem Brihoum; Stephane Supiot; Igor Latorzeff; Stephane Guerif; Tahmineh Romero Kalbasi; Michael L. Steinberg; Luca F. Valle; Kekoa Taparra; Matthew J. Farrell; Jonathan E. Shoag; Jorge A. Garcia; Jason R. Brown; Matthew B. Rettig; Adam E. Singer
err分享
err收藏
COVID-19 Vaccination Before Immune Checkpoint Inhibitor Initiation and the Overall Survival of Patients with Advanced Cancer: a cohort studyCOVID-19疫苗接种前免疫检查点抑制剂启动与晚期癌症患者总生存期：一项队列研究
errEuropean Journal of Cancer
IF7.1
err2026-05-06
err0
PREAI
errPierre-Etienne Heudel; Virginie Avrillon; Benedicte Mastroianni; Helen Boyle; Souad Assaad; Isabelle Ray-Coquard; Jean-Philippe Spano; Sylvie Chabaud; Claire Cropet; Maurice Perol; Jean-Yves Blay
err分享
err收藏
Cabozantinib in Patients with Non-Locally Pretreated Brain Metastases from Renal Cell Carcinoma: Results of the Multicenter Phase II Trial CABRAMET卡博齐坦在非局部预处理的肾细胞癌脑转移患者中的疗效：CABRAMET多中心II期试验结果
errEuropean Journal of Cancer
IF7.1
err2026-04-01
err0
PREAI
errSylvie Negrier; Loïc Mourey; Cécile Dalban; Marine Gross-Goupil; Aude Fléchon; Bernard Escudier; Philippe Barthélémy; Stéphane Oudard; Emeline Colomba; Constance Thibault; Alain Ravaud; Christine Chevreau; Helen Jane Boyle; Ellen Blanc; Sylvie Chabaud; David Pérol; Laurence Albiges; Ronan Flippot
err分享
err收藏
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial – BREASTIMMUNE-03纳武利尤单抗联合伊匹木单抗与卡培他滨作为新辅助化疗后仍有残留病灶的三阴性乳腺癌患者的术后治疗：一项多中心、随机、开放标签的II期试验——BREASTIMMUNE-03
errThe Breast
IF0
err2025-11-21
err0
errOAAI
errOlivier Trédan; Delphine Loirat; Sylvie Chabaud; Philippe Toussaint; Thierry Petit; Frédéric Viret; Christelle Levy; Aurélien Robert; Julien Grenier; Laura Mansi; Jean-Philippe Spano; Anne Patsouris; Olfa Derbel; Christelle Jouannaud; Jean Marc Ferrero; Jean Sébastien Frenel; Yann Molin; Louis Doublet; Pierre-Etienne Heudel; Jean-Yves Pierga
err分享
err收藏
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study转移性透明细胞肾细胞癌中的Nivolumab: 来自NIVOREN getug-afu 26 2期研究的综合生物标志物分析
errEuropean Urology
IF25.2
err2025-11-11
err0
PREAI
errRonan Flippot; Yann-Alexandre Vano; Cécile Dalban; Benoit Beuselinck; Aude Fléchon; Maxime Meylan; Damien Pouessel; Antoine Bougoüin; Catherine Sautes-Fridman; Gwenaelle Gravis; Nathalie Chaput; Stéphane Oudard; Aude Desnoyer; Brigitte Laguerre; Salem Chouaib; Philippe Barthelemy; Delphine Borchiellini; Lucia Carril-Ajuria; Marine Gross-Goupil; Wolf-Herman Fridman; Lionnel Geoffrois; Frederic Rolland; Antoine Thiery-Vuillemin; Florence Joly; Sylvain Ladoire; Florence Tantot; Sylvie Chabaud; Bernard Escudier; Nathalie Rioux-Leclercq; Laurence Albiges
err分享
err收藏
Estimating overall survival by combining administrative and hospital death data: a methodological challenge通过结合行政管理数据和医院死亡数据来估算总生存期：一项方法学挑战
errEuropean Journal of Epidemiology
IF5.9
err2025-10-21
err0
PREAI
errPierre-Yves Cren; Clémence Leguillette; Franck Craynest; Ali Hammoudi; Maël Barthoulot; Matthieu Carton; Thomas Filleron; Sylvie Chabaud; Youenn Drouet; Marie-Cécile Le Deley
err分享
err收藏
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical Trial立体定向调强放疗在根治性前列腺切除术后的应用（SCIMITAR）：一项II期临床试验的4年结果
errEuropean Urology
IF25.2
err2025-09-30
err0
PREAI
errAmar U. Kishan; Jesus E. Juarez Casillas; Paul Sargos; Tahmineh Romero Kalbasi; Sylvie Chabaud; Meryem Brihoum; Ankush Sachdeva; John N. Nikitas; T.Martin Ma; Danielle Karasik; Leslie K. Ballas; Derrick Lock; Luca Valle; Kekoa Taparra; Robert E. Reiter; Christopher Saigal; Karim Chamie; Nicholas Donin; Arnold I. Chin; Matthew Rettig; Nicholas G. Nickols; Yilun Sun; Daniel Spratt; James M. Lamb; Minsong Cao; Pascal Pommier; Michael L. Steinberg
err分享
err收藏
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2− Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial依维莫司每日用药时间与高风险HR+/HER2-早期乳腺癌患者生存的关系：UCBG-UNIRAD试验的亚组分析
errClinical Pharmacology & Therapeutics
IF5.5
err2025-08-24
err0
PREAI
errEnora Laas; Anne-Sophie Hamy; Thomas Bachelot; Paul Gougis; Jérôme Lemonnier; Fabrice André; David Cameron; Judith Bliss; Sylvie Chabaud; Anne-Claire Hardy-Bessard; Magali Lacroix-Triki; Djelila Allouache; Marc Debled; Mario Campone; Laurence Venat-Bouvet; Paul Cottu; Mathilde Martinez; Julien Grenier; Florence Dalenc; Elise Dumas; Fabien Reyal; Bernard Asselain; Frédérique Penault-Llorca; Francis Lévi; Sylvie Giacchetti
err分享
err收藏
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data非转移性前列腺癌术后放疗 (DADSPORT) 的雄激素抑制持续时间: 一项协作系统评价和汇总数据的荟萃分析
errEuropean Urology
IF25.2
err2025-06-26
err0
errOAAI
errSarah Burdett; David J. Fisher; Jayne F. Tierney; Adrian D. Cook; Daniel E. Spratt; James J. Dignam; Wendy F. Seiferheld; Amar U. Kishan; Yilun Sun; Sylvie Chabaud; Jason A. Efstathiou; Christopher C. Parker; Alan Pollack; Paul Sargos; Igor Latorzeff; Meryem Brihoum; Charles N. Catton; Noel W. Clarke; Felix Y. Feng; Theodore G. Karrison; Pascal Pommier; Howard M. Sandler; Matthew R. Sydes; Claire L. Vale
err分享
err收藏
Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin接受恩沃利单抗 vedotin 治疗的患者中，药物相关皮肤不良事件与生存结局的关联。
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2025-06-01
err0
errOAAI
errBelkaid, Samy; Ribereau-Gayon, Emmanuel; Chabaud, Sylvie; Anriot, Julien; Chalas, Thibald; Flechon, Aude; Boyle, Helen; Vinceneux, Armelle; Berard, Frederic; You, Benoit; Freyer, Gilles; Darnis, Sophie; Tartas, Sophie; Amini-Adle, Mona
err分享
err收藏
COREGO: drug–drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trialsCOREGO：regorafenib在软组织肉瘤患者中的药物相互作用对疗效和安全性的影响：REGOSARC和REGOBONE试验数据的合并分析
errESMO Open
IF8.3
err2025-06-01
err0
PREAI
errF. Rethouze; S. Risbourg; C. Schiffler; S. Chabaud; A. de Courrèges; M.-C. Le Deley; J.Y. Blay; F. Feutry; M. Jimenez; M. Vanseymortier; N. Penel; F. Duffaud; L. Lebellec
err分享
err收藏
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial接受伊马替尼治疗的晚期胃肠道间质瘤的二十年生存率：BFR14试验的探索性长期随访
errAnnals of Oncology
IF65.4
err2025-05-28
err0
errOAAI
errJ.-Y. Blay; Q. Devin; M. Toulmonde; A. Dufresne; N. Penel; A. Adenis; M. Rios; F. Bertucci; F. Duffaud; N. Firmin; T. Valentin; E. Bompas; O. Collard; M. Pracht; A. Hervieu; B. Verret; I. Ray-Coquard; P. Cassier; C. Henon; D. Perol; A. Italiano; S. Chabaud; A. Le Cesne
err分享
err收藏
Six years duration of adjuvant imatinib improves disease-free survival in GIST with a high risk of relapse高风险复发风险的GIST患者接受6年辅助伊马替尼治疗可改善无病生存期
errANNALS OF ONCOLOGY
IF65.4
err2025-01-01
err0
PREAI
errBlay, J. -y.; Penel, N.; Schif, C.; Chabaud, S.; Perol, D.; Le Cesne, A.
err分享
err收藏
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse6年与3年伊马替尼辅助治疗局部GIST复发风险高的患者的随机研究
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err6
errOAAI
errBlay, J. -y.; Schiffler, C.; Bouche, O.; Brahmi, M.; Duffaud, F.; Toulmonde, M.; Landi, B.; Lahlou, W.; Pannier, D.; Bompas, E.; Bertucci, F.; Chaigneau, L.; Collard, O.; Pracht, M.; Henon, C.; Ray-Coquard, I.; Armoun, K.; Salas, S.; Spalato-Ceruso, M.; Adenis, A.; Verret, B.; Penel, N.; Moreau-Bachelard, C.; Italiano, A.; Dufresne, A.; Metzger, S.; Chabaud, S.; Perol, D.; Le Cesne, A.
err分享
err收藏
Author's reply to the Letters to the Editor. Six years duration of adjuvant imatinib in high-risk GIST: more to come
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errBlay, J. -y.; Schif, C.; Chabaud, S.; Perolc, D.; Le Cesne, A.
err分享
err收藏
Role of the primary care physician in skin cancer screening: Perspectives of skin cancer patients
errANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
IF2.8
err2024-09-01
err0
errOAAI
errBelkaid, S.; Schenck, M.; Marcoux, M.; Chabaud, S.; Darnis, S.; Amini-Adle, M.
err分享
err收藏
Trifluridine/tipiracil plus oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial
errDIGESTIVE AND LIVER DISEASE
IF3.8
err2024-08-01
err0
errOAAI
errBotsen, Damien; Chabaud, Sylvie; Perrier, Herve; Ammarguellat, Hanifa; Jestin-Le-Tallec, Veronique; Olesinski, Jonathan; Toullec, Clemence; Aparicio, Thomas; Ben Abdelghani, Meher; Borg, Christophe; Bouche, Olivier; Coutzac, Clelia; Devaud, Herve; Di Fiore, Frederic; Dubreuil, Olivier; Evesque, Ludovic; Huguenin, Bruno; Muller, Marie; Poureau, Pierre-Guillaume; Oularue, Emilie; Tougeron, David; Zaanan, Aziz; Ammari, Samy; Carvalho, Nicolas De Sousa; Decazes, Pierre; De La Fouchardiere, Christelle
err分享
err收藏
Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-08-01
err0
PREAI
errBillon, Emilien; Dalban, Cecile; Oudard, Stephane; Chevreau, Christine; Laguerre, Brigitte; Barthelemy, Philippe; Borchiellini, Delphine; Geoffrois, Lionnel; Negrier, Sylvie; Joly, Florence; Thiery-Vuillemin, Antoine; Gross-Goupil, Marine; Rolland, Frederic; Priou, Frank; Mahammedi, Hakim; Tantot, Florence; Escudier, Bernard; Chabaud, Sylvie; Albiges, Laurence; Gravis, Gwenaelle
err分享
err收藏
Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma
errESMO OPEN
IF8.3
err2024-08-01
err0
errOAAI
errDufresne, A.; Pokras, S.; Meurgey, A.; Chabaud, S.; Toulmonde, M.; Bompas, E.; Le Cesne, A.; Robin, Y. -M; Duffaud, F.; Valentin, T.; El Zein, S.; Leroux, A.; Dubray-Longeras, P.; Firmin, N.; de Pinieux, G.; Noal, S.; Delfour, C.; Bollard, J.; Tonon, L.; Biette, A.; Gadot, N.; Attignon, V.; Jean-Denis, M.; Woessner, M.; Klohe, E.; Thayaparan, T.; Eleftheriadou, I.; Blouch, K.; Nathenson, M. J.; Blay, J. -y.
err分享
err收藏
Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial
errEBIOMEDICINE
IF10.8
err2024-06-01
err0
errOAAI
errGiacchetti, Sylvie; Laas, Enora; Bachelot, Thomas; Lemonnier, Jerome; Andre, Fabrice; Cameron, David; Bliss, Judith; Chabaud, Sylvie; Hardy-Bessard, Anne -Claire; Lacroix-Triki, Magali; Canon, Jean -Luc; Debled, Marc; Campone, Mario; Cottu, Paul; Dalenc, Florence; Ballesta, Annabelle; Penault-Llorca, Frederique; Asselain, Bernard; Dumas, Elise; Reyal, Fabien; Gougis, Paul; Levi, Francis; Hamy, Anne-Sophie
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jean‐Yves Blay
H 指数: 158 · 论文数: 2.4K
F
Fabrice André
H 指数: 148 · 论文数: 1.8K
D
Diether Lambrechts
H 指数: 122 · 论文数: 1.3K
R
Renzo Guerrini
H 指数: 116 · 论文数: 2.1K
J
Jaap Verweij
H 指数: 115 · 论文数: 1.1K
查看更多